(MENAFN- EIN Presswire)
Conjugated Monoclonal Antibodies Global Market Report 2023 – Market Size, Trends, And Market Forecast 2023-2032
The Business Research Company's Conjugated Monoclonal Antibodies Global Market Report 2023 – Market Size, Trends, And Market Forecast 2023-2032 The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
” - The Business Research Company
LONDON, GREATER LONDON, UNITED KINGDOM, January 13, 2023 /einpresswire.com / -- The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company's“Conjugated Monoclonal Antibodies Global Market Report 2023” is a comprehensive source of information that covers every facet of the conjugated monoclonal antibodies industry. As per tbrc's conjugated monoclonal antibodies market forecast , the conjugated monoclonal antibodies market is expected to grow from $12.86 billion in 2027 at a CAGR of 5.7%.
The increasing popularity and therapeutic potential of conjugated monoclonal antibodies, especially antibody-drug conjugates, is expected to drive the conjugated monoclonal antibodies market over the forecast period. North America is expected to hold the largest conjugated monoclonal antibodies market share. Major players in the conjugated monoclonal antibodies market include Pfizer Inc., F. Hoffmann-La Roche, Bristol-Myers Squibb, and Merck & Co. Inc., Immunomedics Inc., Takeda Pharmaceuticals Industries Ltd.
Learn More On The Conjugated Monoclonal Antibodies Market By Requesting A Free Sample (Includes Graphs And Tables):
trending conjugated monoclonal antibodies market trend
Companies operating in the conjugated monoclonal antibodies market are focusing on strategic collaborations and partnerships for developing new conjugated monoclonal antibodies and shaping the market. For instance, in June 2020, Monopar Therapeutics, a USA-based biopharmaceutical company, and NorthStar Medical Radioisotopes entered in collaboration to couple Monopar's MNPR-101, a humanised urokinase plasminogen activator receptor (uPAR) targeted monoclonal antibody in pre-IND stage, to a therapeutic radioisotope of NorthStar to create a highly selective agent, that has the potential to kill aberrantly activated cytokine-producing immune cells.
Conjugated Monoclonal Antibodies Market Segments
.By Drugs: Adcetris, Kadcyla
.By Technology: Cleavable Linker, Non-cleavable Linker
.By Application: Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumour, Other Applications
.By Geography: The global conjugated monoclonal antibodies market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read more on the global conjugated monoclonal antibodies market report at:
Conjugated monoclonal antibodies refer to a compound formed from a monoclonal antibody that has been chemically coupled to a medication. The monoclonal antibody binds to particular proteins or receptors that are present on particular cell types, such as cancer cells. The associated medicine enters these cells, kills them, and leaves the rest of the cells alone.
Conjugated Monoclonal Antibodies Global Market Report 2023 from TBRC covers the following information:
.Market size date for the forecast period: Historical and Future
.Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
.Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Conjugated Monoclonal Antibodies Global Market Report 2023 by The Business Research Company is the most comprehensive report that provides insights on conjugated monoclonal antibodies global market size, drivers and trends, conjugated monoclonal antibodies global market major players, competitors' revenues, market positioning, and conjugated monoclonal antibodies market growth across geographies. The conjugated monoclonal antibodies global market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Monoclonal Antibodies MAbS Global Market Report 2023
Antibody Drug Conjugates Global Market Report 2023
Conjugated Monoclonal Antibodies Global Market Report 2023
about the business research company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company's flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Check out our:
Global Market Model:
The Business Research Company
+ +44 20 7193 0708
Visit us on social media:
Market Research Products, Services, Solutions For Your Business - TBRC